Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yingjun Biotech, officially known as Yingjun (Changzhou) Biotechnology, is a specialized life sciences company focused on the development and manufacturing of oligonucleotide-based products. The company provides a comprehensive range of services including the synthesis of high-quality DNA and RNA oligonucleotides, modified nucleic acids, and phosphoramidites for research and therapeutic applications. Yingjun Biotech operates as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), supporting the global biotechnology industry in the advancement of RNA-based therapies and diagnostics. Their technical expertise extends to complex chemical modifications and large-scale production of nucleic acid sequences tailored to specific client requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chang Yingjun.